C122H111N39O11 — CID 157320960
N-methyl-2-[5-[5-(3-methylbutanoylamino)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-methyl-2-[5-[5-(2-methylpropanoylamino)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-methyl-2-[5-[6-(2-oxobutyl)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-methyl-2-[5-[5-(propanoylamino)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-[5-[3-[4-(morpholine-4-carbonyl)-1H-benzimidazol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]propanamide (PubChem CID 157320960) has the molecular formula C122H111N39O11 and a molecular weight of 2299.49 g/mol. Its IUPAC name is N-methyl-2-[5-[5-(3-methylbutanoylamino)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-methyl-2-[5-[5-(2-methylpropanoylamino)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-methyl-2-[5-[6-(2-oxobutyl)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-methyl-2-[5-[5-(propanoylamino)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-[5-[3-[4-(morpholine-4-carbonyl)-1H-benzimidazol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]propanamide.
| Compound Name | N-methyl-2-[5-[5-(3-methylbutanoylamino)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-methyl-2-[5-[5-(2-methylpropanoylamino)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-methyl-2-[5-[6-(2-oxobutyl)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-methyl-2-[5-[5-(propanoylamino)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-[5-[3-[4-(morpholine-4-carbonyl)-1H-benzimidazol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]propanamide |
|---|---|
| PubChem CID | 157320960 |
| Molecular Formula | C122H111N39O11 |
| Molecular Weight | 2299.49 g/mol |
| Exact Mass | 2297.93 |
| IUPAC Name | N-methyl-2-[5-[5-(3-methylbutanoylamino)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-methyl-2-[5-[5-(2-methylpropanoylamino)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-methyl-2-[5-[6-(2-oxobutyl)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-methyl-2-[5-[5-(propanoylamino)-3-pyridinyl]-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-benzimidazole-4-carboxamide;N-[5-[3-[4-(morpholine-4-carbonyl)-1H-benzimidazol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]propanamide |
| SMILES | CCC(=O)Cc1ccc(-c2cnc3n[nH]c(-c4nc5c(C(=O)NC)cccc5[nH]4)c3c2)cn1.CCC(=O)Nc1cncc(-c2cnc3n[nH]c(-c4nc5c(C(=O)N6CCOCC6)cccc5[nH]4)c3c2)c1.CCC(=O)Nc1cncc(-c2cnc3n[nH]c(-c4nc5c(C(=O)NC)cccc5[nH]4)c3c2)c1.CNC(=O)c1cccc2[nH]c(-c3[nH]nc4ncc(-c5cncc(NC(=O)C(C)C)c5)cc34)nc12.CNC(=O)c1cccc2[nH]c(-c3[nH]nc4ncc(-c5cncc(NC(=O)CC(C)C)c5)cc34)nc12 |
| InChI | InChI=1S/C26H24N8O3.C25H24N8O2.C24H22N8O2.C24H21N7O2.C23H20N8O2/c1-2-21(35)29-17-10-15(12-27-14-17)16-11-19-23(32-33-24(19)28-13-16)25-30-20-5-3-4-18(22(20)31-25)26(36)34-6-8-37-9-7-34;1-13(2)7-20(34)29-16-8-14(10-27-12-16)15-9-18-22(32-33-23(18)28-11-15)24-30-19-6-4-5-17(21(19)31-24)25(35)26-3;1-12(2)23(33)28-15-7-13(9-26-11-15)14-8-17-20(31-32-21(17)27-10-14)22-29-18-6-4-5-16(19(18)30-22)24(34)25-3;1-3-16(32)10-15-8-7-13(11-26-15)14-9-18-21(30-31-22(18)27-12-14)23-28-19-6-4-5-17(20(19)29-23)24(33)25-2;1-3-18(32)27-14-7-12(9-25-11-14)13-8-16-20(30-31-21(16)26-10-13)22-28-17-6-4-5-15(19(17)29-22)23(33)24-2/h3-5,10-14H,2,6-9H2,1H3,(H,29,35)(H,30,31)(H,28,32,33);4-6,8-13H,7H2,1-3H3,(H,26,35)(H,29,34)(H,30,31)(H,28,32,33);4-12H,1-3H3,(H,25,34)(H,28,33)(H,29,30)(H,27,31,32);4-9,11-12H,3,10H2,1-2H3,(H,25,33)(H,28,29)(H,27,30,31);4-11H,3H2,1-2H3,(H,24,33)(H,27,32)(H,28,29)(H,26,30,31) |
| InChIKey | BEDPRXWWDDDNGE-UHFFFAOYSA-N |
| XLogP | 17.52 |
| TPSA | 695.11 Ų |
| H-Bond Donors | 18 |
| H-Bond Acceptors | 31 |
| Rotatable Bonds | 27 |
| Heavy Atoms | 172 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2299.49 |
| LogP ≤ 5 | 17.52 |
| H-Bond Donors ≤ 5 | 18 |
| H-Bond Acceptors ≤ 10 | 31 |